Vaccine News and Research

Latest Vaccine News and Research

Microneedles for cancer immunotherapy may lead to minimal invasiveness, side effects

A recent study from the University of Helsinki monitors the breakthrough progresses in the development of microneedles for immunotherapy and discusses the challenges regarding their production.

6 May 2021

Study: Second vaccine dose still makes organ transplant recipients vulnerable to COVID-19

In a study published today in the Journal of the American Medical Association (JAMA), Johns Hopkins Medicine researchers show that although two doses of a vaccine against SARS-CoV-2 - the virus that causes COVID 19 - confers some protection for people who have received solid organ transplants, it's still not enough to enable them to dispense with masks, physical distancing and other safety measures.

6 May 2021

New study documents possible adverse events in relation to Vaxzevria COVID-19 vaccine

The new Danish-Norwegian study is the first study to document possible adverse events in relation to the COVID-19 vaccine Vaxzevria from AstraZeneca, in which all vaccine recipients have been followed systematically, as opposed to previous studies, which have relied primarily on reported adverse reactions.

6 May 2021

Researchers identify potent small molecule TMPRSS2 inhibitor against SARS-CoV-2

A team of scientists from the USA and Canada has recently identified and characterized a novel small-molecule compound inhibitor of cellular serine protease TMPRSS2, which shows significant antiviral potency against emerging variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

5 May 2021

Novel pipeline identifies millions of molecular targets in SARS-CoV-2

Researchers in the United States have developed a novel pipeline for high-throughput, automated annotation of the genes, proteins and functional domains in the genome of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19).

5 May 2021

Prior MMR or Tdap vaccination may reduce risk of severe COVID-19

Researchers in the United States have shown that prior Measles-Mumps-Rubella (MMR) or Tetanus-Diphtheria-pertussis (Tdap) vaccination may reduce the risk of severe outcomes in patients with coronavirus disease 2019 (COVID-19).

5 May 2021

New project aims to develop a digital health solution for promoting COVID-19 vaccination

Patients with compromised health conditions, such as multiple sclerosis, are at enhanced risk of contracting COVID-19.

5 May 2021

Researchers reach new milestone in the development of effective malaria vaccine

Sanaria PfSPZ-CVac" is a live vaccine consisting of infectious Plasmodium falciparum (Pf) malaria parasites that are injected into the subject at the same time as they receive an antimalarial drug.

5 May 2021

Study: Only half of Americans with a history of heart disease get annual flu shot

People with heart disease are more likely to become seriously ill from the flu and other respiratory illnesses, including the coronavirus.

5 May 2021

Women’s views on COVID-19 vaccination during pregnancy: A UK-based study

A new study, recently released as a preprint on the medRxiv* server, describes COVID-19 vaccine willingness among pregnant women in the UK.

5 May 2021

Nanoparticle (SpFN) vaccine candidate elicits multifactorial cellular immune responses against SARS-CoV-2 in vivo

Researchers have developed a promising new anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)vaccine candidate that utilizes nanotechnology and shows robust, long-lived immunity in mouse models.

5 May 2021

Covid shot in the arm not enough to keep pharmacies in business

Tobin's pharmacy and department store had already stocked its shelves with Easter and Mother's Day items last spring, and the staff had just placed the Christmas orders.

5 May 2021

Study reveals missed opportunities to deliver essential preventive care to lupus patients

A new study published in Arthritis Care & Research indicates that few individuals with the autoimmune disease lupus who were publicly insured through Medicaid received recommended vaccines in 2000-2010.

5 May 2021

Stem cell therapy for COVID-19 and ARDS

In a review paper recently uploaded to the journal Biomedicine & Pharmacotherapy by Mahendiratta et al. (May 2021) the applicability of stem cells in treating severe SARS-CoV-2 infection is investigated, with regard to ARDS therapy.

5 May 2021

New book tackles the persistent and controversial questions about COVID

Ohio University mathematics professor Winfried Just's new book COVID-19: Unmasked - The News, the Science, and Common Sense tackles the persistent and sometimes controversial questions people have been asking about COVID-19 in a new, conversational way.

5 May 2021

Pfizer/BioNTech and Moderna vaccines induce T-cell immunity against SARS-CoV-2

Researchers in the United States have shown that the Pfizer/BioNTech and Moderna messenger RNA (mRNA) vaccines are effective at generating T-cell immunity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19).

5 May 2021

Emergency physicians use heparin alternative to treat vaccine-induced blood clot

A new case report, detailed in Annals of Emergency Medicine, is the first known case of a patient with VITT (vaccine-induced thrombotic thrombocytopenia) treated with a heparin alternative following the Centers for Disease Control and Prevention (CDC) guidance.

5 May 2021

Vaccine News and Research

Latest Vaccine News and Research

Microneedles for cancer immunotherapy may lead to minimal invasiveness, side effects

Study: Second vaccine dose still makes organ transplant recipients vulnerable to COVID-19

New study documents possible adverse events in relation to Vaxzevria COVID-19 vaccine

Researchers identify potent small molecule TMPRSS2 inhibitor against SARS-CoV-2

Novel pipeline identifies millions of molecular targets in SARS-CoV-2

Prior MMR or Tdap vaccination may reduce risk of severe COVID-19

New project aims to develop a digital health solution for promoting COVID-19 vaccination

Researchers reach new milestone in the development of effective malaria vaccine

Study: Only half of Americans with a history of heart disease get annual flu shot

Women’s views on COVID-19 vaccination during pregnancy: A UK-based study

Nanoparticle (SpFN) vaccine candidate elicits multifactorial cellular immune responses against SARS-CoV-2 in vivo

Covid shot in the arm not enough to keep pharmacies in business

Study reveals missed opportunities to deliver essential preventive care to lupus patients

Stem cell therapy for COVID-19 and ARDS

New book tackles the persistent and controversial questions about COVID

Pfizer/BioNTech and Moderna vaccines induce T-cell immunity against SARS-CoV-2

Emergency physicians use heparin alternative to treat vaccine-induced blood clot

Pan-COVID-19 vaccine protects mice against SARS-CoV-2 variants

New vaccine candidate provides breakthrough in the fight against malaria

Study reveals no negative effect of SARS-CoV-2 BNT162b2 vaccination on male fertility

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

How the Vutara VXL simplifies single-molecule imaging

How cohesin mechanics and nanotracker tech are redefining DNA research

Todd Bauman and Chris Povich

Vaccine News and Research

Latest Vaccine News and Research

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

How the Vutara VXL simplifies single-molecule imaging

How cohesin mechanics and nanotracker tech are redefining DNA research

Todd Bauman and Chris Povich

Newsletters you may be interested in